Delivery Order SPE2DB24D1104-SPE2DB25FXZA5
Award Date
3/21/25
Potential Completion Date
3/24/25
Potential Value
$1.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of WEGOVY 1.7 MG/0.75 ML PEN 0.75ML, a medication used for the treatment of chronic weight management. The contract has a ceiling value of $4,914.00 and a period of performance through February 27, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $27,606.19 contract is for the supply of WEGOVY 0.5 MG/0.5 ML PEN 0.5ML, a medication used in the treatment of obesity and related conditions. The contract has a period of performance through December 18, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
This is a $7,467.03 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, a medication used for chronic weight management. The contract has an ultimate completion date of February 28, 2025 and is not designated as a set-aside. AmerisourceBergen has a significant $999,999,999 Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of WEGOVY 1.7 MG/0.75 ML PEN 0.75ML, a medication used for weight management. The contract has a ceiling value of $4,811.88 and is a Firm Fixed Price Delivery Order that runs through May 29, 2024. This contract award is part of a larger Indefinite Delivery Contract...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,923.00 firm fixed-price delivery order contract is for the supply of WEGOVY 1.7 MG/0.75 ML PEN 0.75ML, a medication used in the treatment of obesity. The contract has an ultimate completion date of March 24, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $28,303.78 firm-fixed-price contract is for the supply of WEGOVY 0.5 MG/0.5 ML PEN 0.5ML, a medication used for weight management. The contract has an ultimate completion date of December 11, 2024. This award is part of AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,535.46 firm fixed-price delivery order contract is for the supply of WEGOVY 0.5 MG/0.5 ML PEN 0.5ML, a medication used in the treatment of obesity and related conditions. The contract has an ultimate completion date of January 16, 2025 and was awarded on January 15, 2025. This order is part of a larger...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a medication used for weight management. The contract has a firm fixed price of $1,228.50 and an ultimate completion date of March 18, 2025. The award is not associated with a set-aside program, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $20,175.66, is for the supply of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a medication used in the treatment of chronic weight management. The contract is a firm-fixed price delivery order, with a period of performance running through March 4, 2025. It is not designated as a set-aside...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a medication used in the treatment of chronic weight management. The contract has a ceiling value of $2,473.80 and a term running through January 3, 2025. The contract is structured as a Firm Fixed Price arrangement. This award is associated with a larger...